281 related articles for article (PubMed ID: 28034887)
1. Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System.
Allan-Blitz LT; Humphries RM; Hemarajata P; Bhatti A; Pandori MW; Siedner MJ; Klausner JD
Clin Infect Dis; 2017 May; 64(9):1268-1270. PubMed ID: 28034887
[TBL] [Abstract][Full Text] [Related]
2. A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection.
Allan-Blitz LT; Hemarajata P; Humphries RM; Wynn A; Segura ER; Klausner JD
Sex Transm Dis; 2018 Feb; 45(2):87-91. PubMed ID: 29329176
[TBL] [Abstract][Full Text] [Related]
3. Improved determination of Neisseria gonorrhoeae gyrase A genotype results in clinical specimens.
Allan-Blitz LT; Ellis OL; Wee R; Truong A; Ebeyan SM; Tan LY; Mokany E; Flynn R; Klausner JD
J Antimicrob Chemother; 2019 Oct; 74(10):2913-2915. PubMed ID: 31340021
[TBL] [Abstract][Full Text] [Related]
4. A multisite implementation of a real-time polymerase chain reaction assay to predict ciprofloxacin susceptibility in Neisseria gonorrhoeae.
Ellis O; Hemarajata P; Shahkolahi A; Masinde G; Buchs K; Humphries RM; Klausner JD
Diagn Microbiol Infect Dis; 2019 Jul; 94(3):213-217. PubMed ID: 30723007
[TBL] [Abstract][Full Text] [Related]
5. Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis.
Allan-Blitz LT; Wang X; Klausner JD
Sex Transm Dis; 2017 May; 44(5):261-265. PubMed ID: 28407640
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin May be Efficacious in Treating Wild-Type Gyrase A Genotype Neisseria gonorrhoeae Infections.
Allan-Blitz LT; Hemarajata P; Humphries RM; Kimble M; Elias S; Klausner JD
Sex Transm Dis; 2018 Apr; 45(4):e18. PubMed ID: 29465685
[No Abstract] [Full Text] [Related]
7. Epidemiology of Neisseria gonorrhoeae Gyrase A Genotype, Los Angeles, California, USA.
Bhatti AA; Allan-Blitz LT; Castrejon M; Humphries RM; Hemarajata P; Klausner JD
Emerg Infect Dis; 2017 Sep; 23(9):1581-1584. PubMed ID: 28820375
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of endemic ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool.
Corkill JE; Komolafe AJ; Neal TJ; Mortimore A; Alawattegama AB; Hart CA
Int J STD AIDS; 2003 Jun; 14(6):379-85. PubMed ID: 12816664
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.
Ebeyan S; Windsor M; Bordin A; Mhango L; Erskine S; Trembizki E; Mokany E; Tan LY; Whiley D;
J Antimicrob Chemother; 2019 Jul; 74(7):1820-1824. PubMed ID: 30897201
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility profile of
Affolabi D; Goma E; Sogbo F; Ahotin G; Orekan J; Massou F; Behanzin L; Guédou F; Alary M
Sex Transm Infect; 2018 Feb; 94(1):20. PubMed ID: 29021407
[No Abstract] [Full Text] [Related]
12. Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of N. gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
Zhao L; Liu A; Li R; Zhao S
Int J Antimicrob Agents; 2018 Jan; 51(1):52-56. PubMed ID: 28729124
[TBL] [Abstract][Full Text] [Related]
13. Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin.
Trembizki E; Guy R; Donovan B; Kaldor JM; Lahra MM; Whiley DM;
Lancet Infect Dis; 2016 Sep; 16(9):1005-1006. PubMed ID: 27684341
[No Abstract] [Full Text] [Related]
14. Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.
Whiley DM; Trembizki E; Buckley C; Freeman K; Baird RW; Beaman M; Chen M; Donovan B; Kundu RL; Fairley CK; Guy R; Hogan T; Kaldor JM; Karimi M; Limnios A; Regan DG; Ryder N; Su JY; Ward J; Lahra MM
Emerg Infect Dis; 2017 Sep; 23(9):1478-1485. PubMed ID: 28820128
[TBL] [Abstract][Full Text] [Related]
15. Multiplex Real-Time PCR Assay for Simultaneous Identification of Neisseria gonorrhoeae and Its Ciprofloxacin Susceptibility Status.
Perera SR; Khan NH; Martin I; Taheri A; Parti RP; Levett PN; Horsman GB; Kusalik A; Dillon JR
J Clin Microbiol; 2017 Nov; 55(11):3201-3209. PubMed ID: 28814585
[TBL] [Abstract][Full Text] [Related]
16. Resistance-Guided Therapy for Neisseria gonorrhoeae.
Allan-Blitz LT; Adamson PC; Klausner JD
Clin Infect Dis; 2022 Oct; 75(9):1655-1660. PubMed ID: 35818315
[TBL] [Abstract][Full Text] [Related]
17. A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia.
Lahra MM; Ryder N; Whiley DM
N Engl J Med; 2014 Nov; 371(19):1850-1. PubMed ID: 25372111
[No Abstract] [Full Text] [Related]
18. Simultaneous Detection of Neisseria gonorrhoeae and Fluoroquinolone Resistance Mutations to Enable Rapid Prescription of Oral Antibiotics.
de Korne-Elenbaas J; Pol A; Vet J; Dierdorp M; van Dam AP; Bruisten SM
Sex Transm Dis; 2020 Apr; 47(4):238-242. PubMed ID: 32022739
[TBL] [Abstract][Full Text] [Related]
19. Performance and Verification of a Real-Time PCR Assay Targeting the gyrA Gene for Prediction of Ciprofloxacin Resistance in Neisseria gonorrhoeae.
Hemarajata P; Yang S; Soge OO; Humphries RM; Klausner JD
J Clin Microbiol; 2016 Mar; 54(3):805-8. PubMed ID: 26739156
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009).
Vandepitte J; Hughes P; Matovu G; Bukenya J; Grosskurth H; Lewis DA
Sex Transm Dis; 2014 Apr; 41(4):233-7. PubMed ID: 24622633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
